“…Human influenza virus A H7/N9, [33][34][35] MERS-coronavirus, 36 Staphylococcus aureus, 37 38 Salmonella typhimurium, 39 Streptococcus pneumoniae, 28 40 Enterococcus spp 41 Pathogen risk assessment Identification of targets for assays differentiating highly virulent pathogen strains Influenza virus H5/N1, 22 23 Chlamydia trachomatis 42 43 Distinguishing recent from pre-existing (chronic) infection Mycobacterium tuberculosis 44 45 Redefining periods of transmissibility MRSA, 46 group A streptococcus 47 Detection, monitoring, and control of hospital acquired outbreaks Identification of new clones associated with hospital acquired pathogens Acinetobacter baumannii, 48 49 S aureus, 50 Escherichia coli, 51 52 Pseudomonas aeruginosa 53 Near real time identification of transmission events (patient to patient, healthcare staff to patient, environment to patient)* S aureus, [53][54][55][56][57][58][59] Clostridium difficile, 53-55 60 Klebsiella pneumoniae 61 Monitoring transmission and (antimicrobial resistance) gene flow between healthcare institutions C difficile, 56 S aureus, 62 HIV, 63 norovirus, 64 human influenza virus 65 Improved resolution of regional, national, and global public health laboratory surveillance Detection of outbreaks, covert clusters, and associated risk factors Neisseria meningitidis, 66 Salmonella enterica, 67 enterohaemorrhagic E coli, 51 68 M tuberculosis 4 69 70 Reconstruction of outbreak origins, transmission pathways and dating of transmission events within community outbreaks (person to person contact, water and food borne modes of direct transmission)* Ebola virus, 71 enterovirus, 72 Vibrio cholerae, 73 74 Mycobacterium tuberculosis, 4 46 75-78 g...…”